1 Product identity
Ingredient risk
Contains restricted ingredients

DHEA 50 mg

BrandAmerifitOther Combinations Tablet or Pill 9 ingredients 1 banned 1 caution DSLD #25850
Net contents: 50 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-10-25
2 Ingredients (9)
IngredientGroupSafety
Vitamin CVitamin CGenerally Safe
DehydroepiandrosteroneDHEABanned in ≥1 country
Dicalcium PhosphateCalciumConditionally Safe
Microcrystalline CelluloseCellulose
Stearic AcidStearic Acid
Magnesium StearateMagnesiumUse with Caution
SilicaSiliconGenerally Safe
Croscarmellose SodiumCroscarmellose Sodium
natural coatingCoating
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⛔ Contains an ingredient banned in ≥1 country
DHEA  🇨🇦 🇬🇧 🇪🇺 🇦🇺 — Not approved for OTC sale as supplement.
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Vitamin C — Generally Safe
⚠ GI distress at high doses
⚠ Kidney stones risk >1g/day
DHEA — Banned in ≥1 country
⚠ Hormonal: acne, hirsutism, voice deepening
⚠ May promote hormone-sensitive cancers
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Silicon — Generally Safe
⚠ Very low toxicity
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
4 Label claims
• All Other
5 Data source
DSLD ID25850
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-10-25
6 More from Amerifit
View Amerifit Safety Scorecard → 3 products
DHA SoftgelPrenatal Multivitamin
7 Cite this page
Vancouver
Pkhakadze G. DHEA 50 mg — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jun 24]. Available from: https://supplement.ge/products/dhea-50-mg-25850/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG